We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-5.86%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.62B
AUM Growth
-$2.78B
Cap. Flow
-$2.47B
Cap. Flow %
-43.88%
Top 10 Hldgs %
56.27%
Holding
465
New
101
Increased
59
Reduced
84
Closed
204

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$44.1M
2
HRMY icon
Harmony Biosciences
HRMY
+$36.9M
3
TVTX icon
Travere Therapeutics
TVTX
+$33.9M
4
MDLN
Medline Inc
MDLN
+$22.4M
5
META icon
Meta Platforms (Facebook)
META
+$20.9M

Top Sells

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$70.6M
2
IMVT icon
Immunovant
IMVT
+$56.5M
3
XRAY icon
Dentsply Sirona
XRAY
+$53.6M
4
GEHC icon
GE HealthCare
GEHC
+$53.1M
5
PTCT icon
PTC Therapeutics
PTCT
+$51.5M

Sector Composition

Rank Sector Weight
1 Healthcare 38.27%
2 Technology 7.29%
3 Consumer Discretionary 4.25%
4 Communication Services 1.58%
5 Consumer Staples 1.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KO icon
376
Coca-Cola
KO
$365B
– –
-3,754
Closed -$262K
KRE icon
377
State Street SPDR S&P Regional Banking ETF
KRE
$4.97B
– –
-3,238
Closed -$210K
DFSC
378
DEFSEC Technologies
DFSC
$5.2M
– –
-158,036
Closed -$269K
LAZ icon
379
Lazard
LAZ
$4.28B
– –
-6,064
Closed -$294K
LH icon
380
Labcorp
LH
$23.1B
– –
-911
Closed -$229K
LIVN icon
381
LivaNova
LIVN
$4.49B
– –
-9,325
Closed -$574K
LNC icon
382
Lincoln National
LNC
$8.01B
– –
-6,731
Closed -$300K
LNG icon
383
Cheniere Energy
LNG
$54.3B
– –
-1,213
Closed -$236K
LTH icon
384
Life Time Group Holdings
LTH
$9.54B
– –
-58,882
Closed -$1.57M
LULU icon
385
lululemon athletica
LULU
$13.5B
– –
-3,561
Closed -$740K
LW icon
386
Lamb Weston
LW
$6.48B
– –
-18,012
Closed -$755K
LYV icon
387
Live Nation Entertainment
LYV
$41.9B
– –
-120,938
Closed -$17.2M
M icon
388
Macy's
M
$6.34B
– –
-44,866
Closed -$989K
MCK icon
389
McKesson
MCK
$98.5B
– –
-11,363
Closed -$9.32M
MCY icon
390
Mercury Insurance
MCY
$5.95B
– –
-7,221
Closed -$679K
MDT icon
391
Medtronic
MDT
$107B
– –
-271,241
Closed -$26.1M
MGRX icon
392
Mangoceuticals
MGRX
$6.67M
– –
-1,536,000
Closed -$1.14M
MLI icon
393
Mueller Industries
MLI
$13B
– –
-5,072
Closed -$291K
MNST icon
394
Monster Beverage
MNST
$97.7B
– –
-38,912
Closed -$2.98M
MO icon
395
Altria Group
MO
$122B
– –
-14,406
Closed -$831K
MOBBW
396
Mobilicom Ltd Warrants
MOBBW
$3.12B
– –
-242,100
Closed -$780K
MOS icon
397
The Mosaic Company
MOS
$7.16B
– –
-12,389
Closed -$298K
MSCI icon
398
MSCI
MSCI
$46.4B
– –
-731
Closed -$419K
MTCH icon
399
Match Group
MTCH
$9.4B
– –
-90,641
Closed -$2.93M
MTD icon
400
Mettler-Toledo International
MTD
$27B
– –
-340
Closed -$474K
14 15
16
17 18

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Armistice Capital held 465 positions worth $5.62B, down 33% from $8.4B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Armistice Capital withdrew a net $2.47B in Q1 2026, closing 204 positions and reducing 84 holdings. Its most notable exit was argenx, an estimated $48.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 33% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Armistice Capital opened a new position in UnitedHealth worth $40M.

  • Armistice Capital's largest Q1 2026 buy was UnitedHealth: 148,000 shares worth $40M.
  • Armistice Capital added most to Harmony Biosciences in Q1 2026, an estimated $36.9M increase.
  • Armistice Capital's biggest Q1 2026 reduction was Kenvue, cutting an estimated $70.6M.
  • Armistice Capital fully exited argenx in Q1 2026, selling an estimated $48.8M.
  • Armistice Capital's ten largest holdings make up 56% of its $5.62B portfolio in Q1 2026.
  • Armistice Capital opened 101 new positions and closed 204 in Q1 2026.
  • Armistice Capital's portfolio value fell 33% quarter-over-quarter to $5.62B.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.